Juvederm Vollure™ XC

Allergan, the pharmaceutical company who developed the filler Juvéderm, recently announced some very exciting news: One of its new fillers has been granted FDA-approval. The filler, called JUVÉDERM VOLLURE™ XC, is now the first and only hyaluronic acid dermal filler approved for the correction of moderate to severe wrinkles and folds that lasts up to 18 months in people over the age of 21.

The news of this approval comes after an exciting clinical trial featuring the filler came to a close, revealing some promising findings. According to the trial, 59 percent of subjects saw improvement in nasolabial folds for up to 18 months, a substantial finding considering that most fillers typically last only about a year. Additionally, patient satisfaction in the study was also significant, with 82 percent of patients saying they were very satisfied after six months and 68 percent still claiming satisfaction at 18 months.

If you would like more information about JUVÉDERM VOLLURE™ XC, you can call, email or schedule a consultation with our office.